Thank you!
Thank you for your interest in this survey report! Please download it below.
Use the insights from “Navigating The Funding Obstacle Course Of 2023” to inform your critical funding strategies for the year to come. Tap into the results from a recent biopharma industry poll measuring the trends and challenges in current biopharma investing.
Access the analysis
Understand what’s coming next as the industry enters a new year, accompanied by economic uncertainty, global conflict, and inflation worries.
Don’t miss these critical insights from Citeline’s Scrip and PPD, a part of Thermo Fisher Scientific. Tap into insider perspectives on future funding expectations, biotech investor priorities, de-risking development plans, co-funding opportunities, and top funding considerations.>